DTX2 and hepatocellular carcinoma: Reparixin effectively blocked the increase in neutrophil chemotaxis induced by DTX2 overexpression in HCC cells (Figure 3K) without affecting neutrophil apoptosis (Figure S9E, Supporting Information).